You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cisplatin resistancy

Showing 1 - 25 of 2,498
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Testicular Cancer Trial in Worldwide (cabazitaxel)

Recruiting
  • Testicular Cancer
  • Copenhagen, Denmark
  • +4 more
Jul 18, 2022

Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)

Recruiting
  • Neoadjuvent
  • +3 more
  • Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
  • Xi'an, Shaanxi, China
  • +2 more
Aug 17, 2023

Ototoxicity, Drug-Induced Trial in Cincinnati (Sodium Thiosulfate)

Recruiting
  • Ototoxicity, Drug-Induced
  • Sodium Thiosulfate
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Mar 6, 2023

Drug Toxicity Trial in Rawalpindi (N-Acetylcysteine, Chemotherapy)

Active, not recruiting
  • Drug Toxicity
  • Rawalpindi, Punjab, Pakistan
    Medical Oncology department, Fauji Foundation Hospital
Aug 25, 2023

Pancreatic Cancer Trial in Baltimore (Gemcitabine, Cisplatin, Pembrolizumab)

Not yet recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    SKCCC Johns Hopkins
Aug 16, 2023

Locally Advanced Unresectable Esophageal Squamous Carcinoma Trial in Jinan, Tianjin (Docetaxel for Injection (Albumin-bound),

Not yet recruiting
  • Locally Advanced Unresectable Esophageal Squamous Carcinoma
  • Docetaxel for Injection (Albumin-bound)
  • +4 more
  • Jinan, Shandong, China
  • +1 more
Nov 16, 2023

Endothelial Function in Germ Cell Tumor Patients Treated With

Active, not recruiting
  • Germ Cell Cancer
  • Endo-PAT2000 testing
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 7, 2022

Biliary Tract Tumors, Gallbladder Cancer, Cholangiocarcinoma Trial in Seoul (Durvalumab + Gem/Cis, Gem/Cis)

Active, not recruiting
  • Biliary Tract Neoplasms
  • +2 more
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 30, 2023

Ovarian Cancer, Malignant Tumor of Uterus Trial in New York (Sacituzumab, Cisplatin)

Not yet recruiting
  • Ovarian Cancer
  • Malignant Neoplasm of Uterus
  • New York, New York
    Icahn School of Medicine at Mount Sinai Division of Hematology a
Sep 14, 2023

Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in United States (Nivolumab, Cisplatin, Cetuximab)

Completed
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Palo Alto, California
  • +10 more
Nov 22, 2022

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Trial

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Biospecimen Collection
  • +9 more
  • (no location specified)
Oct 10, 2023

Renal Insufficiency, Cis-Platinum Nephropathy Trial in Bangkok (short hydration, conventional hydration)

Recruiting
  • Renal Insufficiency
  • Cis-Platinum Nephropathy
  • short hydration
  • conventional hydration
  • Bangkok, Thailand
    Faculty of Medicine Siriraj Hospital
May 23, 2023

Biliary Tract Carcinoma Trial in China (Pembrolizumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Biliary Tract Carcinoma
  • Pembrolizumab
  • +3 more
  • Hefei, Anhui, China
  • +21 more
Aug 16, 2022

Intrahepatic Cholangiocarcinoma Trial (procedure, drug, biological)

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Biopsy
  • +7 more
  • (no location specified)
Sep 21, 2023

Nephrotoxicity Trial in Denver, New York (Granisetron, Ondansetron, Palonosetron)

Recruiting
  • Nephrotoxicity
  • Denver, Colorado
  • +1 more
Oct 31, 2022

Neuroendocrine Carcinoma of the Bladder, Bladder Cancer Trial (Adebrelimab, Etoposide, Cisplatin)

Not yet recruiting
  • Neuroendocrine Carcinoma of the Bladder
  • Bladder Cancer
  • (no location specified)
Oct 14, 2023

Epithelial Ovarian Cancer, Acute Kidney Injury Due to Circulatory Failure Trial (Sodium Sulfate, Hydration, Cisplatin)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Acute Kidney Injury Due to Circulatory Failure
  • Sodium Sulfate
  • +2 more
  • (no location specified)
May 17, 2023

Oral Mucositis Trial (RRx-001, Intensity Modulated Radiation Therapy (IMRT), Cisplatin for injection 100 mg/m2)

Not yet recruiting
  • Oral Mucositis
  • (no location specified)
Jul 31, 2023

METASTATIC CERVICAL CANCER Trial (QL1706, Placebo)

Recruiting
  • METASTATIC CERVICAL CANCER
  • Chongqing, Chongqing, China
  • +2 more
Nov 24, 2022

Urothelial Carcinoma Trial in France, Italy, United States (retifanlimab, epacadostat, INCAGN02385)

Recruiting
  • Urothelial Carcinoma
  • Iowa City, Iowa
  • +11 more
Dec 1, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +32 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Chemo;Advanced Gastric Cancer;Cisplatin;Disulfiram Trial in Hangzhou (disulfiram and cisplatin, cisplatin)

Not yet recruiting
  • Chemotherapy；Advanced Gastric Cancer；Cisplatin；Disulfiram
  • Hangzhou, Zhejiang, China
    Hangzhou first people's Hospital
Dec 26, 2022

NSCLC (NSCLC) Trial in Worldwide (Tiragolumab, Atezolizumab, Pemetrexed)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • Jonesboro, Arkansas
  • +138 more
Jan 17, 2023

Urothelial Carcinoma Trial in Iowa City (Avelumab, Docetaxel)

Active, not recruiting
  • Urothelial Carcinoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 18, 2022

Pancreatic Adenocarcinoma, Homologous Recombination Deficiency Trial (Cisplatin)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Homologous Recombination Deficiency
  • (no location specified)
Oct 18, 2023